China's Market Regulator Says 'Stabilising Confidence' Key
Wu Qing, who took over as the head of China's Securities Regulatory Commission a year ago when China's stock markets were sliding, said regulators had been working to restore confidence since late ...
Le Lézard3d
Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European Union
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...
Japan's Rakuten Group scraps plan to list Rakuten Securities
Japan's Rakuten Group has decided not to seek a listing for Rakuten Securities on the Tokyo Stock Exchange, it said on ...
Deepseek's Shock In Wider US Vs China Perspective
The most interesting thing about the DeepSeek-driven stock reckoning is what this moment says about the globe's two biggest ...
FDA Approves LEQEMBI (Lecanemab-Irmb) IV Maintenance Dosing For The Treatment Of Early Alzheimer's Disease
IV Maintenance Dosing for the treatment of Early Alzheimer's Disease Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease ...